Skip to main content
. 2022 Feb 9;15:17562848221074188. doi: 10.1177/17562848221074188

Figure 1.

Figure 1.

Flow chart and time course of patients treated with golimumab during follow-up.

PMS, partial Mayo Score; SIBDC, Swiss Inflammatory Bowel Disease Cohort; UC, ulcerative colitis.